 Clinical Study
June 20, 2025
In a groundbreaking presentation at the AAAAI 2025 conference, Celldex Therapeutics showcased compelling preclinical data for its bispecific antibody program, CDX-622. This innovative therapeutic candidate targets critical pathways involved in inflammatory skin diseases, demonstrating significant potential for futur...
|
Announcement
June 20, 2025
In a recent announcement, STMicroelectronics N.V. reported the current status of its common share repurchase program, which aims to enhance shareholder value. The company has undertaken this initiative with the expectation of using its strong cash flow to buy back shares, a move that is often seen as a vote of confi...
|
Announcement
June 20, 2025
Abstract: Enlivex Therapeutics Ltd. has reported compelling interim results from its Phase I clinical trial of Allocetra, an innovative macrophage reprogramming immunotherapy. This article examines the data from the study, which focuses on the treatment of moderate to severe knee osteoarthritis and highlights the ...
|
|
 Clinical Study
June 20, 2025
Advancement in Hypoparathyroidism Treatment: MBX Biosciences’ Phase 2 Avail Trial of MBX 2109 Concludes Enrollment MBX Biosciences has reached a significant milestone in the development of its promising treatment for hypoparathyroidism with the completion of participant enrollment in the Phase 2 Avail trial for MB...
 Clinical Study
June 20, 2025
Abstract: NKGen Biotech is at the forefront of developing innovative cellular therapies, including Troculeucel, which shows promise in treating post-stroke and Alzheimer’s disease (AD) patients. Recent advancements include the administration of Troculeucel to a stroke patient under an FDA-cleared compassionate use...
|
|
Our most Popular Articles
|
Clinical Study
August 26, 2024
In recent news from the biotechnology and skincare sectors, Elevai Labs Inc. has reported promising outcomes from a clinical study conducted on its topical product, Elevai Enfinityâ„¢. The study, executed by Elevai s subsidiary, Elevai Skincare Inc. showcased positive data results that could signify a breakthrough i...
|
Contract
November 10, 2025
In a noteworthy development that emphasizes Codexis, Inc. s strategic expansion and robust performance in the competitive biopharmaceutical landscape, the company announced on November 10, 2025, the signing of a lease for a state-of-the-art 34,000 square foot Good Manufacturing Practices (GMP) manufacturing facility...
|
Business Update
September 21, 2024
SAN FRANCISCO In a significant move, Wells Fargo Bank, N.A. announced today that it is reducing its prime interest rate from 8.50 percent to 8.00 percent. This change will take effect starting tomorrow, September 19, 2024. The decision reflects the bank s adaptive strategy in a dynamic financial environment and a...
|
|
|
Company News
|
Announcement
June 20, 2025
In a recent announcement, STMicroelectronics N.V. reported the current status of its common share repurchase program, which aims to enhance shareholder value. The company has undertaken this initiative with the expectation of using its strong cash flow to buy back shares, a move that is often seen as a vote of confi...
|
Announcement
June 20, 2025
Abstract: Enlivex Therapeutics Ltd. has reported compelling interim results from its Phase I clinical trial of Allocetra, an innovative macrophage reprogramming immunotherapy. This article examines the data from the study, which focuses on the treatment of moderate to severe knee osteoarthritis and highlights the ...
|
Contract
June 20, 2025
SciSparc Ltd. (Nasdaq: SPRC), an innovative clinical-stage pharmaceutical company dedicated to pioneering therapies for challenging central nervous system disorders, has been in the news for a series of significant strategic maneuvers aimed at strengthening its market position and broadening its operational sphere. ...
|
|
|
Company News
 Product Service News
June 20, 2025
|
Company News
 Announcement
June 20, 2025
|
Company News
 Business Update
June 20, 2025
|
More Company News
|
Business Update
June 20, 2025
|
Business Update
June 20, 2025
|
Business Update
June 20, 2025
|
Business Update
June 20, 2025
|
Business Update
June 20, 2025
|
Partnership
June 20, 2025
|
Partnership
June 20, 2025
|
Partnership
June 20, 2025
|
Product Service News
June 20, 2025
|
Product Service News
June 20, 2025
|
|
|
|
Related News
|
Announcement
|
Clinical Study
|
|
Stocks
|
Product Service News
|
Product Service News
|
Announcement
|
|
|
|
Business News
|
|
Clinical Study
Advancement in Hypoparathyroidism Treatment: MBX Biosciences’ Phase 2 Avail Trial of MBX 2109 Concludes Enrollment MBX Biosciences has reached a significant milestone in the development of its promising treatment for hypoparathyroidism with the completion of participant enrollment in the Phase 2 Avail trial for MB...
|
|
Clinical Study
Abstract: NKGen Biotech is at the forefront of developing innovative cellular therapies, including Troculeucel, which shows promise in treating post-stroke and Alzheimer’s disease (AD) patients. Recent advancements include the administration of Troculeucel to a stroke patient under an FDA-cleared compassionate use...
|
 Announcement
for CSIMarket.com On March 3, 2025, Allarity Therapeutics, Inc. (NASDAQ: ALLR), a clinical-stage pharmaceutical company focused on developing personalized cancer therapies, announced an authorization from its Board of Directors for a share repurchase program amounting to $5 million. This program is to be execute...
|
 Announcement
Abstract: Chemomab Therapeutics Ltd. recently announced its financial results for the fourth quarter and the year ended 2024, revealing mixed outcomes regarding its performance relative to competitors in the pharmaceutical sector. While the company reported promising results from its Phase 2 trial for nebokitug in p...
|
|
Clinical Study
In a groundbreaking presentation at the AAAAI 2025 conference, Celldex Therapeutics showcased compelling preclinical data for its bispecific antibody program, CDX-622. This innovative therapeutic candidate targets critical pathways involved in inflammatory skin diseases, demonstrating significant potential for futur...
|
Our Most Popular Articles
|
|
Clinical Study
In recent news from the biotechnology and skincare sectors, Elevai Labs Inc. has reported promising outcomes from a clinical study conducted on its topical product, Elevai Enfinityâ„¢. The study, executed by Elevai s subsidiary, Elevai Skincare Inc. showcased positive data results that could signify a breakthrough i...
|
 Contract
In a noteworthy development that emphasizes Codexis, Inc. s strategic expansion and robust performance in the competitive biopharmaceutical landscape, the company announced on November 10, 2025, the signing of a lease for a state-of-the-art 34,000 square foot Good Manufacturing Practices (GMP) manufacturing facility...
|
 Business Update
SAN FRANCISCO In a significant move, Wells Fargo Bank, N.A. announced today that it is reducing its prime interest rate from 8.50 percent to 8.00 percent. This change will take effect starting tomorrow, September 19, 2024. The decision reflects the bank s adaptive strategy in a dynamic financial environment and a...
|
More News
|
 Announcement
In a recent announcement, STMicroelectronics N.V. reported the current status of its common share repurchase program, which aims to enhance shareholder value. The company has undertaken this initiative with the expectation of using its strong cash flow to buy back shares, a move that is often seen as a vote of confi...
|
 Announcement
Abstract: Enlivex Therapeutics Ltd. has reported compelling interim results from its Phase I clinical trial of Allocetra, an innovative macrophage reprogramming immunotherapy. This article examines the data from the study, which focuses on the treatment of moderate to severe knee osteoarthritis and highlights the ...
|
 Contract
SciSparc Ltd. (Nasdaq: SPRC), an innovative clinical-stage pharmaceutical company dedicated to pioneering therapies for challenging central nervous system disorders, has been in the news for a series of significant strategic maneuvers aimed at strengthening its market position and broadening its operational sphere. ...
|
 Product Service News
In a strategic move aimed at securing critical infrastructure communications, Actelis Networks Inc. has announced a follow-on order to expand its deployment of cyber-hardened networking solutions for a major utility provider in Hungary. This initiative is poised to enhance the security of vital communications for en...
|
 Announcement
Clash of Titans: The Howard Hughes-Pershing Square Saga Unfolds In a gripping chapter of corporate maneuvering, Howard Hughes Holdings Inc. (NYSE: HHH) has made its latest move in the ongoing engagement with Pershing Square Capital Management L.P., a tale that promises to capture the attention of investors and marke...
|
 Business Update
Zai Lab Limited, a burgeoning pharmaceutical company with listings on NASDAQ (ZLAB) and the Hong Kong Stock Exchange (9688), is set to enhance its visibility and investor engagement through participation in key investor conferences in March 2025. With events like the Leerink Partners 2025 Global Healthcare Conferenc...
|
 Business Update
In a significant move that underscores its commitment to Puerto Rico s energy landscape, New Fortress Energy Inc. (NASDAQ: NFE) has announced a one-year extension of its 80 trillion British thermal unit (TBtu) islandwide gas supply contract with the Puerto Rico Electric Power Authority (PREPA). This extension is piv...
|
 Business Update
KalVista Pharmaceuticals Unveils New Sebetralstat Data at AAAAI WAO 2025 Joint Congress: Promising Advances in Treating Hereditary Angioedema CAMBRIDGE, Mass. & SALISBURY, England KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) has announced its commitment to advancing the field of hereditary angioedema (HAE) trea...
|
 Business Update
In a dynamic strategy to diversify its audience engagement while strengthening its core financial services, Fifth Third Bank (NASDAQ: FITB) has announced two significant accomplishments: the creation of Team Fifth Third, a novel Name, Image, and Likeness (NIL) program, and its recent accolade as the United States B...
|
 Business Update
F5 and NVIDIA Join Forces to Revolutionize AI at the Edge with BIG-IP Next and BlueField-3 DPUs Barcelona, Spain - Mobile World Congress - In a strategic leap forward, F5 (NASDAQ: FFIV) announced its latest advancement in network technology through a deepened collaboration with NVIDIA, unveiling the integration of...
|
 Business Update
Adicet Bio Pioneers Allogeneic Gamma Delta T Cell Therapies as It Prepares to Showcase Breakthrough Findings at SITC 2025 In a transformative era for cancer therapy and autoimmune disease treatment, Adicet Bio, Inc. (Nasdaq: ACET), a clinical-stage biotechnology company specializing in allogeneic gamma delta T cell ...
|
 Partnership
In a landmark initiative aimed at invigorating the independent filmmaking landscape, Vimeo has unveiled its inaugural Short Film Grant, a collaborative effort with industry titans Nikon and RED. This program, designed to provide substantial support to emerging filmmakers, will award up to $150,000 to facilitate the ...
|
|
Partnership
Getty Images and UEFA Extend Partnership Amid Challenging Financial Performance Washington, D.C. Getty Images, a global leader in visual content, has announced the renewal of its multi-year partnership with the Union of European Football Associations (UEFA), reinforcing its role as UEFA s official appointed photographic agency. This agreement secures Getty Images position as a primary provider of photographic content and images for Europe s governing body of football tournaments, including the prized UEFA Champions League and the UEFA European Championship, among others.The collaboration, which has been beneficial to both organizations, allows UEFA to leverage Getty Images extensive expertise in sports photography, ensuring high-quality visual documentation of its competitions and events. This partnership extension underscores Getty Images prowess and reliability in delivering compelling sports photography, crucial for engaging audiences in today s digital age.
|
|
Partnership
In an era where the intersection of technology and healthcare is becoming increasingly critical, the recent partnership between Counterpart Health and Google Cloud marks a significant evolution in how physicians can access and utilize clinical data. This collaboration introduces enhanced functionality within the Cou...
|
 Product Service News
In the competitive landscape of the fast-casual dining space, Portillo s is making waves with innovative strategies designed to deepen customer engagement and enhance its culinary offerings. Recently, the iconic Chicago eatery unveiled its first-ever loyalty program, Portillo s Perks, aimed at reshaping the customer...
|
 Product Service News
LPL Financial LLC, one of the leading broker-dealers and registered investment advisory firms in the United States, has recently announced the addition of Michael Carmichael, RFC, CRPS, to its roster of financial advisors. A recognized name in the industry, Carmichael is the founder of Carmichael Financial and bring...
|
|
|
|
|
